CASE PRESENTATION 1 | DAY 1: 2.30 PM - 4.00 PM
by Fumiyo Oshima, Ida Shaw, and Pierre Cousineau
Title: Individual Schema Therapy for high-functioning autism spectrum disorder with comorbid psychiatric conditions in Young Adults: Results of a Naturalistic Multiple Case Study
Presenters: Fumiyo Oshima and discussant Ida Shaw
Schema Therapy (ST) approaches to high-functioning autism spectrum disorder (HF-ASD) in young people have yet to demonstrate differential effectiveness, and there is little evidence that young people with HF-ASD adapt ST.
We conducted a pilot study and case series for HF-ASD in adolescents. We first included patients with HF-ASD (N = 9) into a 4-week baseline phase; this phase functioned as a no-treatment control condition. Then patients began a 5–20-week exploration phase during which symptoms and underlying schemas were explored; this phase functioned as a dysfunctional emotional and behavioural control condition. Next, the treatment phase, the patients received up to 25 sessions of individual ST. WHO-QOL and The Global Assessment of Functioning (GAF) were the primary outcome measures.
The treatment period showed a significant effect on QOL and GAF scores over the no-treatment control period. In this three-case series, all four participants reported severe maladjustment at baseline and achieved remission by the end of treatment.
Conclusions: Schema Therapy shows promise as a treatment for young adults with HF-ASD.
Points of Discussion:
About the Presenters:
Fumiyo Oshima, Ph.D.
Certified Clinical Psychologist in Tokyo, Japan
Presently, a Trainer-Supervisor Schema Therapist in Japan.
Conducted clinical study of Schema Therapy for Autistic people.
Ida Shaw, M.A. is the Training Director of the Center for Borderline Personality Disorder Treatment and Research, IUPUI. She is a member of the Training and Certification Advisory Board of ISST and Chair of the Child-Adolescent Certification Committee. Ida is the main clinical supervisor of the international BPD trial of group schema therapy, providing training and supervision for all trial therapists. She supervises the practice component of additional research projects on Avoidant personality disorder, dissociative disorders, complex trauma and child-adolescent treatment.
Pierre Cousineau, Ph.D.
Advanced Schema Therapist and Supervisor
Associate Instructor of the Coherence Psychology Institute
Ph.D. from University of Waterloo (Ontario, Canada)
Pierre practices psychotherapy for +40 years in Montréal, Canada. He practices Schema Therapy since the mid-90s. He has integrated Mindfulness, ACT, and Coherence Therapy to its Schema Therapy practice. He is doing groups’ and individuals’ supervisions. Heahs given many workshops on Schema Therapy, ACT, and Coherence Therapy – in Canada (mainly), France (regularly), Morocco, Switzerland, Norway. He has published papers and books’ chapters on Schema Therapy. He has supervised the translation and written the Foreword of the French version of “Reinventing your Life” (more than 100,000 copies sold in French speaking countries).
©2019 International Society of Schema Therapy e.V.
International Society of Schema Therapy e.V. is a not-for-profit organization. Glossop-Ring 35, DE-61118 Bad Vilbel, Germany
Why Schema Therapy?
Schema therapy has been extensively researched to effectively treat a wide variety of typically treatment resistant conditions, including Borderline Personality Disorder and Narcissistic Personality Disorder. Read our summary of the latest research comparing the dramatic results of schema therapy compared to other standard models of psychotherapy.